Targeting Urokinase and the Transferrin Receptor with Novel, Anti-Mitotic N-Alkylisatin Cytotoxin Conjugates Causes Selective Cancer Cell Death and Reduces Tumor Growth
Kara L. Vine(University of Wollongong), Marie Ranson(University of Wollongong), Jodi Lee(University of Wollongong), Julie M. Locke, Lidia Matesic, John B. Bremner(University of Wollongong), Danielle Skropeta(University of Wollongong), Vineesh Indira Chandran(Aarhus University)
Cited by 21
Related Papers
Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: Challenges and opportunities
|Journal of Controlled Release|2018|297
Cytotoxic and Anticancer Activities of Isatin and Its Derivatives: A Comprehensive Review from 2000-2008
|Anti-Cancer Agents in Medicinal Chemistry|2009|269
Biopolymers for Antitumor Implantable Drug Delivery Systems: Recent Advances and Future Outlook
|Advanced Materials|2018|217
In vitro cytotoxicity evaluation of some substituted isatin derivatives
|Bioorganic & Medicinal Chemistry|2006|193
An Investigation into the Cytotoxicity and Mode of Action of Some Novel <i>N</i>-Alkyl-Substituted Isatins
|Journal of Medicinal Chemistry|2007|150